Dual Approach Using Unbiased Proteomics and Multiplexed Immunofluorescence for the Detection of Markers Predictive for Immunotherapy in Melanoma Patients - Biognosys

Dual Approach Using Unbiased Proteomics and Multiplexed Immunofluorescence for the Detection of Markers Predictive for Immunotherapy in Melanoma Patients

Posters

Poster 1267/14 presented at AACR 2022

Presenter: Jakob Vowinckel
Session: PO.CL11.07 Biomarkers Predictive of Therapeutic Benefit 2
Date: April 11

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More